Skip to content

SANARA MEDTECH INC.: 10-Q filed 2023-11-13

What SANARA MEDTECH INC. reported in its quarterly report filed 2023-11-13 (fiscal Q3 2023): 51 published measures, 142 facts as tagged in accession 0001493152-23-040475.

This filing

Form
10-Q (quarterly report)
Filed
2023-11-13
Fiscal period
fiscal Q3 2023
Accession
0001493152-23-040475 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SANARA MEDTECH INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-09-3075,474,072USD
At 2022-12-3161,035,386USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2023-09-3031,376,282USD
At 2022-12-3119,315,411USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-09-3044,316,800USD
At 2022-12-3141,827,530USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2023-09-306,235,912USD
At 2022-12-318,958,995USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-1,060,370USD92
2023-01-01 to 2023-09-30-4,066,003USD273
2022-07-01 to 2022-09-30-1,470,460USD92
2022-01-01 to 2022-09-30-3,830,358USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-2,397,024USD273
2022-01-01 to 2022-09-30-4,909,854USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2023-01-01 to 2023-09-30210,970USD273
2022-01-01 to 2022-09-3093,651USD273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2023-07-01 to 2023-09-3016,024,948USD92
2023-01-01 to 2023-09-3047,300,029USD273
2022-07-01 to 2022-09-3013,044,571USD92
2022-01-01 to 2022-09-3030,526,572USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-01-01 to 2023-09-309,827,011USD273
2022-01-01 to 2022-09-30-322,931USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-10,153,070USD273
2022-01-01 to 2022-09-30-3,134,676USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-09-30-27,799,621USD
At 2022-12-31-23,394,757USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2023-07-01 to 2023-09-308,332,341shares92
2023-01-01 to 2023-09-308,244,503shares273
2022-07-01 to 2022-09-308,107,261shares92
2022-01-01 to 2022-09-307,836,882shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2023-07-01 to 2023-09-308,332,341shares92
2023-01-01 to 2023-09-308,244,503shares273
2022-07-01 to 2022-09-308,107,261shares92
2022-01-01 to 2022-09-307,836,882shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-0.13USD/shares92
2023-01-01 to 2023-09-30-0.49USD/shares273
2022-07-01 to 2022-09-30-0.18USD/shares92
2022-01-01 to 2022-09-30-0.49USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-0.13USD/shares92
2023-01-01 to 2023-09-30-0.49USD/shares273
2022-07-01 to 2022-09-30-0.18USD/shares92
2022-01-01 to 2022-09-30-0.49USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-1,702,890USD92
2022-01-01 to 2022-09-30-5,844,796USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2023-09-301,327,056USD
At 2022-12-311,416,436USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-07-01 to 2023-09-30857,526USD92
2023-01-01 to 2023-09-302,582,163USD273
2022-07-01 to 2022-09-30683,202USD92
2022-01-01 to 2022-09-301,971,537USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-906,655USD92
2023-01-01 to 2023-09-30-3,989,158USD273
2022-07-01 to 2022-09-30-3,232,142USD92
2022-01-01 to 2022-09-30-9,394,006USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-09-3019,375,303USD
At 2022-12-3120,616,509USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2023-07-01 to 2023-09-30188,294USD92
2023-01-01 to 2023-09-30188,300USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-09-3013,227,076USD
At 2022-12-3112,806,309USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2023-09-303,601,781USD
At 2022-12-313,601,781USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2023-09-3045,991,466USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2023-07-01 to 2023-09-3015,180,254USD92
2023-01-01 to 2023-09-3045,224,663USD273
2022-07-01 to 2022-09-3014,048,152USD92
2022-01-01 to 2022-09-3035,928,850USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2023-09-305,021,030USD
At 2022-12-313,549,000USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2023-07-01 to 2023-09-3014,273,599USD92
2023-01-01 to 2023-09-3041,235,505USD273
2022-07-01 to 2022-09-3010,816,010USD92
2022-01-01 to 2022-09-3026,534,844USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2023-07-01 to 2023-09-301,751,349USD92
2023-01-01 to 2023-09-306,064,524USD273
2022-07-01 to 2022-09-302,228,561USD92
2022-01-01 to 2022-09-303,991,728USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2023-07-01 to 2023-09-3013,877,879USD92
2023-01-01 to 2023-09-3040,658,424USD273
2022-07-01 to 2022-09-3012,062,195USD92
2022-01-01 to 2022-09-3031,865,958USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2023-07-01 to 2023-09-30986,454USD92
2023-01-01 to 2023-09-303,480,906USD273
2022-07-01 to 2022-09-301,061,387USD92
2022-01-01 to 2022-09-302,333,024USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-09-308,540,226shares
At 2022-12-318,299,957shares

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2023-09-3044,097,790USD
At 2023-06-3040,964,498USD
At 2023-03-3141,478,770USD
At 2022-12-3141,719,975USD
At 2022-09-3044,648,468USD
At 2022-06-3039,465,089USD
At 2022-03-3128,515,686USD
At 2021-12-3130,152,004USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2023-09-302,094,188USD
At 2022-12-31806,402USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2023-09-302,168,499USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2023-09-309,690,397USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2023-09-302,399,804USD
At 2022-12-312,156,422USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2023-09-301,072,748USD
At 2022-12-31739,986USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2023-09-3045,991,466USD
At 2022-12-3131,509,980USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2023-09-304,871,986USD
At 2022-12-316,003,811USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2023-09-30621,690USD
At 2022-12-311,104,611USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-1,094,949USD92
2023-01-01 to 2023-09-30-4,177,458USD273
2022-07-01 to 2022-09-30-3,232,142USD92
2022-01-01 to 2022-09-30-9,773,639USD273

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-1,094,949USD92
2023-01-01 to 2023-09-30-4,177,458USD273
2023-04-01 to 2023-06-30-1,866,180USD91
2023-01-01 to 2023-03-31-1,216,329USD90
2022-07-01 to 2022-09-30-1,529,252USD92
2022-01-01 to 2022-09-30-3,928,843USD273
2022-04-01 to 2022-06-30756,914USD91
2022-01-01 to 2022-03-31-3,156,505USD90

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2023-07-01 to 2023-09-30116,596USD92
2023-01-01 to 2023-09-30332,762USD273
2022-07-01 to 2022-09-30106,347USD92
2022-01-01 to 2022-09-30300,655USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2023-07-01 to 2023-09-30881,079USD92
2023-01-01 to 2023-09-302,247,482USD273
2022-07-01 to 2022-09-30708,534USD92
2022-01-01 to 2022-09-301,256,097USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-188,294USD92
2023-01-01 to 2023-09-30-188,300USD273
2022-01-01 to 2022-09-30-379,633USD273

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-5,844,796USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2023-01-01 to 2023-09-30146,546USD273

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2023-01-01 to 2023-09-30264,291USD273
2022-01-01 to 2022-09-30210,897USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-09-30794,344USD273
2022-01-01 to 2022-09-30754,934USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-09-301,664,714USD273
2022-01-01 to 2022-09-30451,838USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-09-30547,186USD273
2022-01-01 to 2022-09-30-800,788USD273

Inspect the source

Entity
SANARA MEDTECH INC. / CIK 0000714256
Captured
2026-09-19T14:58:44.284Z
SEC response SHA-256
f92965785fd765218c7d077735cf7f10feb84c027a40423c2ef31995cf28b81f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000714256.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))